Healthy adult
Conditions
Sponsors
HUMA R&D CORP
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Age: 30 and over, below 45 2)Sex: Males and females with Japanese nationality 3)Individuals with a BMI of 23 or more and less than 30 at screening (high-normal and 1st-degree obesity)
Exclusion criteria
Exclusion criteria: 1)People who regularly drink or drink yogurt containing lactobacilli *Yogurt consumption will not be excluded if habit exists during the study 2)Persons who are unable to limit the use of drugs, health foods, foods for specified health use, functional labeling foods, health supplements, supplements, etc., which may affect body fat, as well as foods high in lactobacilli and oligosaccharides after obtaining informed consent 3)Subjects who were receiving medication at the time of study entry and were attending the clinic for body fat-related disease 4)Persons with or with a history of diseases such as diabetes, liver disease, kidney disease, or heart disease 5)Persons who have been diagnosed with familial hyperlipidemia 6)Persons currently undergoing exercise and diet therapy under the supervision of a physician 7)Persons who regularly engage in strenuous exercise 8)Persons with diseases requiring constant medication 9)Persons with a history of serious disease requiring medical treatment 10)Persons with a history of drug or food allergy 11)Patients who have metal in the CT scan measurement site due to surgery, etc. 12)Patients with cardiac pacemakers or implantable cardioverter defibrillators. 13)People with claustrophobia 14)Subjects who are judged inappropriate as subjects based on the responses to the background questionnaire 15)Subjects with significant deviations from reference ranges in pre-test physical, physical, and laboratory measurements 16)Pregnant, lactating women, or women who wish to become pregnant during the study 17)Persons with a current or past history of psychiatric disorders 18)Persons who work shift,such as night shift workers 19)Patients who are receiving or have a history of drug dependence or drug abuse. 20)Individuals who have participated in other human clinical studies or are currently participating in other human clinical studies within the past 3months 21)Other subjects who are considered inappropriate as subjects 22)Meetings are required
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visceral fat area, body composition (body weight, body mass index, body fat percentage), and abdominal circumference | — |
Secondary
| Measure | Time frame |
|---|---|
| Hematologic test, blood biochemical test, vital signs | — |
Countries
Japan
Contacts
Public ContactOchitani Daisuke
HUMA R&D CORP Clinical Development Division
Outcome results
None listed